Literature DB >> 26929198

New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling.

Monika Bambouskova1, Iva Polakovicova1, Ivana Halova1, Gautam Goel2, Lubica Draberova1, Viktor Bugajev1, Aivi Doan2, Pavol Utekal1, Agnes Gardet2, Ramnik J Xavier2, Petr Draber3.   

Abstract

Aggregation of the high-affinity receptor for IgE (FcεRI) in mast cells initiates activation events that lead to degranulation and release of inflammatory mediators. To better understand the signaling pathways and genes involved in mast cell activation, we developed a high-throughput mast cell degranulation assay suitable for RNA interference experiments using lentivirus-based short hairpin RNA (shRNA) delivery. We tested 432 shRNAs specific for 144 selected genes for effects on FcεRI-mediated mast cell degranulation and identified 15 potential regulators. In further studies, we focused on galectin-3 (Gal3), identified in this study as a negative regulator of mast cell degranulation. FcεRI-activated cells with Gal3 knockdown exhibited upregulated tyrosine phosphorylation of spleen tyrosine kinase and several other signal transduction molecules and enhanced calcium response. We show that Gal3 promotes internalization of IgE-FcεRI complexes; this may be related to our finding that Gal3 is a positive regulator of FcεRI ubiquitination. Furthermore, we found that Gal3 facilitates mast cell adhesion and motility on fibronectin but negatively regulates antigen-induced chemotaxis. The combined data indicate that Gal3 is involved in both positive and negative regulation of FcεRI-mediated signaling events in mast cells.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26929198      PMCID: PMC4836217          DOI: 10.1128/MCB.00064-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Small interfering RNA screen for phosphatases involved in IgE-mediated mast cell degranulation.

Authors:  Juan Zhang; Mary Mendoza; Michel F Guiraldelli; Emilia Alina Barbu; Reuben P Siraganian
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background.

Authors:  Claude Haan; Iris Behrmann
Journal:  J Immunol Methods       Date:  2006-11-02       Impact factor: 2.303

4.  Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells.

Authors:  Rossella Paolini; Rosa Molfetta; Laurie O Beitz; Juan Zhang; Andrew M Scharenberg; Mario Piccoli; Luigi Frati; Reuben Siraganian; Angela Santoni
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

5.  Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

Authors:  Emily A Partridge; Christine Le Roy; Gianni M Di Guglielmo; Judy Pawling; Pam Cheung; Maria Granovsky; Ivan R Nabi; Jeffrey L Wrana; James W Dennis
Journal:  Science       Date:  2004-10-01       Impact factor: 47.728

6.  Transmembrane adaptor protein PAG/CBP is involved in both positive and negative regulation of mast cell signaling.

Authors:  Lubica Draberova; Viktor Bugajev; Lucie Potuckova; Ivana Halova; Monika Bambouskova; Iva Polakovicova; Ramnik J Xavier; Brian Seed; Petr Draber
Journal:  Mol Cell Biol       Date:  2014-09-22       Impact factor: 4.272

Review 7.  Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.

Authors:  Gabriel A Rabinovich; Marta A Toscano
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

8.  Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.

Authors:  C S Lantz; T F Huff
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

9.  1,2-propanediol-trehalose mixture as a potent quantitative real-time PCR enhancer.

Authors:  Helena Horáková; Iva Polakovičová; Gouse M Shaik; Jiří Eitler; Viktor Bugajev; Lubica Dráberová; Petr Dráber
Journal:  BMC Biotechnol       Date:  2011-04-18       Impact factor: 2.563

10.  H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.

Authors:  A M Schmitt-Verhulst; C B Pettinelli; P A Henkart; J K Lunney; G M Shearer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  9 in total

1.  6-O-angeloylplenolin inhibits anti-IgE-stimulated human mast cell activation via suppressing calcium influx and ERK phosphorylation.

Authors:  Yangyang Yu; Dongxu Lin; Zhenyu Liu; Ran Fang; Siman Zheng; Yongxian Cheng; Zhong Huang; Chun Wai Ng; Hang Yung Alaster Lau
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

Review 2.  The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens.

Authors:  Laura Díaz-Alvarez; Enrique Ortega
Journal:  Mediators Inflamm       Date:  2017-05-11       Impact factor: 4.711

3.  Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.

Authors:  Lucie Potuckova; Lubica Draberova; Ivana Halova; Tomas Paulenda; Petr Draber
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

4.  Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients.

Authors:  Simone M Hayen; Constance F den Hartog Jager; André C Knulst; Edward F Knol; Johan Garssen; Linette E M Willemsen; Henny G Otten
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

Review 5.  Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target.

Authors:  Milica Velickovic; Aleksandar Arsenijevic; Aleksandar Acovic; Dragana Arsenijevic; Jelena Milovanovic; Jelena Dimitrijevic; Zeljko Todorovic; Marija Milovanovic; Tatjana Kanjevac; Nebojsa Arsenijevic
Journal:  Front Pharmacol       Date:  2021-03-19       Impact factor: 5.810

Review 6.  Galectin-3 in Cardiovascular Diseases.

Authors:  Valeria Blanda; Umberto Marcello Bracale; Maria Donata Di Taranto; Giuliana Fortunato
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

7.  The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19.

Authors:  Hao Li; Jianmin Li; Wei Xiao; Yujing Zhang; Yuan Lv; Xing Yu; Jiao Zheng
Journal:  Front Mol Biosci       Date:  2021-05-24

Review 8.  Galectin-3 Is a Potential Mediator for Atherosclerosis.

Authors:  Ziyu Gao; Zhongni Liu; Rui Wang; Yinghong Zheng; Hong Li; Liming Yang
Journal:  J Immunol Res       Date:  2020-02-14       Impact factor: 4.818

Review 9.  The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases.

Authors:  Grażyna Sygitowicz; Agata Maciejak-Jastrzębska; Dariusz Sitkiewicz
Journal:  Biomolecules       Date:  2021-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.